ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
about
Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcomaInduction of stemlike cells with fibrogenic properties by carbon nanotubes and its role in fibrogenesisAnticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cellsCancer stem cells (CSCs), cervical CSCs and targeted therapiesEsophageal cancer stem cells and implications for future therapeuticsLung cancer stem cells: progress and prospectsUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionCardiac side population cells: moving toward the center stage in cardiac regenerationCancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinomaA new prospect in cancer therapy: targeting cancer stem cells to eradicate cancerResearch progress and prospects of markers for liver cancer stem cellsInduction of cancer stem cell properties in colon cancer cells by defined factorsCD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantumBidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneityThe Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaActions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer riskBreast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonistGlycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cellsEvaluation of 309 environmental chemicals using a mouse embryonic stem cell adherent cell differentiation and cytotoxicity assayAldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcomaABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cellsPhenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic targetAn overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.Lung cancer stem cell: new insights on experimental models and preclinical data.In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1+/CD31+ side-population cells).Dehydroabietic acid derivative QC2 induces oncosis in hepatocellular carcinoma cells.Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell lineABCG2 is required to control the sonic hedgehog pathway in side population cells with stem-like properties.Stem cell pathways contribute to clinical chemoresistance in ovarian cancerOxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2.Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity.A combination of curcumin with either gramicidin or ouabain selectively kills cells that express the multidrug resistance-linked ABCG2 transporterAn endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells.Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves.The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cellsHuman adult stem cells maintain a constant phenotype profile irrespective of their origin, Basal media, and long term cultures.Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo.
P2860
Q21560783-0CE6662E-CA9D-46CE-A819-C91CCA725E2DQ23921932-D7745747-BF7A-4477-A633-29E90DFA4A49Q24628715-A6FA3F37-6C89-4F7A-B928-8565BC3A48B8Q26747144-E73F2B64-B918-4B6A-A0E9-A142B9A98084Q26752943-B6EA47BC-06AC-4353-8C79-CC5C55483104Q26827654-C86B7FF5-5D7C-4A95-BECF-EE30CE9AED05Q26829949-91C03361-8023-4911-802E-089CE07F1FB4Q26862552-85CB106C-0A66-45B3-81E6-16DC0B69C935Q26998068-70B1D648-63A0-4EF7-A984-802771B136A9Q27022134-863DEE1F-8F67-45B7-92A7-8AA0A05BEC50Q27022262-CF6DAD69-80A0-4C34-B6B0-7243AC4DEB59Q27320228-8CD2545E-3FE9-4A0D-B82A-EE7A3DD3B7D0Q27321912-9309F86F-B22C-4F6C-8B06-348400430C19Q28066409-420E2779-DC56-427B-9C37-919917FAC3D2Q28071619-C516C176-6ED1-44A6-92AA-D47E36EBC963Q28395212-B02C532F-DFA9-42DF-831F-28EE4E2BA381Q28475994-1E756883-2492-4B89-A979-FEBEBB780EE8Q28477764-EAA9BEA4-F1BB-4201-8C8C-1A7D87755ABFQ28478482-6AF58479-CD8C-48A1-A599-EEB3B6B6AA84Q28482489-87A68B8B-CF34-42DF-924A-9450D4DC84E0Q30393893-BAFD3538-E9A9-40E1-A482-9FB735D4C7BEQ30419235-C5B7F8D7-0E86-4914-8DE4-84A6459A63C5Q33275167-9F0E65AB-9301-4D8A-BA3F-222CDDF1CD23Q33739392-E0F41F97-6880-4831-B8F6-ED883EA0630FQ33786637-2C463112-AEBB-465E-B236-971ACF6FC98AQ33912811-468908FD-71A2-4982-85F2-E17C3F55D7F1Q33943367-C37CC32F-ED76-46DF-9E3A-449EDC6BEF5CQ33961677-BEA7ABA2-D4FF-47A9-BF9A-5466E1DE64E8Q33966214-C460BDE7-4CA4-4666-9699-0414705B75D2Q34092005-B2295AD6-48C3-4CB2-8AA8-09A907721664Q34124903-41AA7F96-9568-43D6-BC44-A0A451665EBBQ34253081-4512E2BC-219A-41B2-ACA8-458A9A0EAA2BQ34414027-36D7DDC1-589B-4B07-8CB0-4358C1C07537Q34449025-CCE07510-002E-4FF6-B630-11F1CABDD664Q34467622-250BCBCD-C9A9-40F9-83EB-E2D4ED02031BQ34615538-6D236FF6-0E6A-48F6-9ABD-A13C52FEAA51Q34920768-A75F832C-1DC4-4A01-9C96-90AC5C6077DEQ35000256-E88C2229-563E-4407-841E-15C7715389C0Q35061505-9AECBF6D-4B4B-4FE2-BEF6-8DA93B208DE0Q35067898-E8226B29-36F7-45D9-BC68-DDBC109D0CD0
P2860
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
@en
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
@nl
type
label
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
@en
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
@nl
prefLabel
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
@en
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
@nl
P2093
P1433
P1476
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
@en
P2093
Chun-ping Jiang
Jun-hua Wu
Xi-wei Ding
P304
P356
10.1016/J.LFS.2010.02.012
P407
P577
2010-02-14T00:00:00Z